Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database
Jean Ruelle(University Colleges Leuven-Limburg), Patrick Goubau(UCLouvain), Chris Verhofstede(Ghent University), Dolorès Vaira(University of Liège), Christine Lambert(Pacific Biosciences (United States)), Fedoua Echahidi(Universitair Ziekenhuis Brussel), François Roman(GlaxoSmithKline (Belgium)), Katrien Fransen(KU Leuven), Jean‐Claude Schmit(Laboratoire National de Santé), Anne-Thérèse Vandenbroucke(UCLouvain), Kristel Van Laethem(KU Leuven), Marie‐Luce Delforge(Université Libre de Bruxelles), Denis Piérard(Vrije Universiteit Brussel)
Cited by 47
Related Papers
Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature
|Journal of Clinical Microbiology|2012|828
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium
|JAMA|2020|352
Chimpanzee Adenovirus Vector Ebola Vaccine
|New England Journal of Medicine|2014|284
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
|The Lancet Infectious Diseases|2015|217
Invasive aspergillosis in patients with severe alcoholic hepatitis
|Journal of Hepatology|2013|149